Canary Speech Showcases AI Vocal Biomarker Tech at HIMSS with Microsoft

Canary Speech, a leader in AI-driven vocal biomarker technology, will be featured within the Microsoft Booth at the HIMSS conference in Las Vegas from March 3rd to 6th. Announced in a press release, this collaboration highlights Canary Speech's strategic partnership with Microsoft, which began last year.

The company utilizes Microsoft Cloud for Healthcare to expand its operations across the U.S., Japan, U.K., and South America. By integrating with Microsoft Azure, Canary Speech enables healthcare organizations to purchase software subscriptions for early disease detection and impairment monitoring through vocal biomarker analysis.

Henry O'Connell, CEO of Canary Speech, emphasized the transformative potential of AI-enabled vocal biomarkers in healthcare, providing real-time insights that enhance clinical decision-making. This partnership with Microsoft is seen as a significant step in advancing digital transformation in healthcare, leveraging voice as a critical tool for improving patient outcomes.